Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

646 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease.
Lundin A, Dietrichs E, Haghighi S, Göller ML, Heiberg A, Loutfi G, Widner H, Wiktorin K, Wiklund L, Svenningsson A, Sonesson C, Waters N, Waters S, Tedroff J. Lundin A, et al. Among authors: waters s, waters n. Clin Neuropharmacol. 2010 Sep-Oct;33(5):260-4. doi: 10.1097/WNF.0b013e3181ebb285. Clin Neuropharmacol. 2010. PMID: 20616707 Clinical Trial.
In vivo pharmacology of the dopaminergic stabilizer pridopidine.
Ponten H, Kullingsjö J, Lagerkvist S, Martin P, Pettersson F, Sonesson C, Waters S, Waters N. Ponten H, et al. Among authors: waters s, waters n. Eur J Pharmacol. 2010 Oct 10;644(1-3):88-95. doi: 10.1016/j.ejphar.2010.07.023. Epub 2010 Jul 24. Eur J Pharmacol. 2010. PMID: 20667452 Free article.
Extrastriatal dopamine D(2) receptor binding in Huntington's disease.
Esmaeilzadeh M, Farde L, Karlsson P, Varrone A, Halldin C, Waters S, Tedroff J. Esmaeilzadeh M, et al. Among authors: waters s. Hum Brain Mapp. 2011 Oct;32(10):1626-36. doi: 10.1002/hbm.21134. Epub 2010 Sep 30. Hum Brain Mapp. 2011. PMID: 20886576 Free PMC article.
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.
Waters S, Sonesson C, Svensson P, Tedroff J, Carta M, Ljung E, Gunnergren J, Edling M, Svanberg B, Fagerberg A, Kullingsjö J, Hjorth S, Waters N. Waters S, et al. Among authors: waters n. J Pharmacol Exp Ther. 2020 Jul;374(1):113-125. doi: 10.1124/jpet.119.264226. Epub 2020 May 1. J Pharmacol Exp Ther. 2020. PMID: 32358046
(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.
Hjorth S, Waters S, Waters N, Tedroff J, Svensson P, Fagerberg A, Edling M, Svanberg B, Ljung E, Gunnergren J, McLean SL, Grayson B, Idris NF, Neill JC, Sonesson C. Hjorth S, et al. Among authors: waters s, waters n. J Pharmacol Exp Ther. 2020 Sep;374(3):404-419. doi: 10.1124/jpet.120.000037. Epub 2020 Jun 30. J Pharmacol Exp Ther. 2020. PMID: 32605972
Network interactions in schizophrenia - therapeutic implications.
Carlsson A, Waters N, Waters S, Carlsson ML. Carlsson A, et al. Among authors: waters s, waters n. Brain Res Brain Res Rev. 2000 Mar;31(2-3):342-9. doi: 10.1016/s0165-0173(99)00050-8. Brain Res Brain Res Rev. 2000. PMID: 10719161 Review.
Localization of urea transporter B in the developing bovine rumen.
Zhong C, Lyons T, Heussaff O, Doyle E, O'Hara E, Waters SM, Kenny D, Stewart GS. Zhong C, et al. Among authors: waters sm. Anim Nutr. 2022 Apr 28;10:216-222. doi: 10.1016/j.aninu.2022.03.006. eCollection 2022 Sep. Anim Nutr. 2022. PMID: 35785258 Free PMC article.
Response to Xiao et al.: If everything is a loot box, nothing is.
Zendle D, Cairns P, Meyer R, Waters S, Ballou N. Zendle D, et al. Among authors: waters s. Addiction. 2022 Sep;117(9):2555-2556. doi: 10.1111/add.15976. Epub 2022 Jul 5. Addiction. 2022. PMID: 35722786 No abstract available.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial.
Howell SJ, Casbard A, Carucci M, Ingarfield K, Butler R, Morgan S, Meissner M, Bale C, Bezecny P, Moon S, Twelves C, Venkitaraman R, Waters S, de Bruin EC, Schiavon G, Foxley A, Jones RH. Howell SJ, et al. Among authors: waters s. Lancet Oncol. 2022 Jul;23(7):851-864. doi: 10.1016/S1470-2045(22)00284-4. Epub 2022 Jun 4. Lancet Oncol. 2022. PMID: 35671774 Free article. Clinical Trial.
Correction to: The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age‑matched controls.
Lawn W, Fernandez-Vinson N, Mokrysz C, Hogg G, Lees R, Trinci K, Petrilli K, Borissova A, Ofori S, Waters S, Michór P, Wall MB, Freeman TP, Curran HV. Lawn W, et al. Among authors: waters s. Psychopharmacology (Berl). 2022 Jul;239(7):2371. doi: 10.1007/s00213-022-06169-7. Psychopharmacology (Berl). 2022. PMID: 35648202 Free PMC article. No abstract available.
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression.
Wildiers H, Meyskens T, Marréaud S, Lago LD, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Meulemans B, Sousa B, Poncet C, Brain E. Wildiers H, et al. Among authors: waters s. Breast. 2022 Aug;64:100-111. doi: 10.1016/j.breast.2022.05.004. Epub 2022 May 20. Breast. 2022. PMID: 35636341 Free PMC article. Clinical Trial.
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
Bidard FC, Kaklamani VG, Neven P, Streich G, Montero AJ, Forget F, Mouret-Reynier MA, Sohn JH, Taylor D, Harnden KK, Khong H, Kocsis J, Dalenc F, Dillon PM, Babu S, Waters S, Deleu I, García Sáenz JA, Bria E, Cazzaniga M, Lu J, Aftimos P, Cortés J, Liu S, Tonini G, Laurent D, Habboubi N, Conlan MG, Bardia A. Bidard FC, et al. Among authors: waters s. J Clin Oncol. 2022 May 18:JCO2200338. doi: 10.1200/JCO.22.00338. Online ahead of print. J Clin Oncol. 2022. PMID: 35584336
Dementia risk in a diverse population: A single-region nested case-control study in the East End of London.
Bothongo PLK, Jitlal M, Parry E, Waters S, Foote IF, Watson CJ, Cuzick J, Giovannoni G, Dobson R, Noyce AJ, Mukadam N, Bestwick JP, Marshall CR. Bothongo PLK, et al. Among authors: waters s. Lancet Reg Health Eur. 2022 Feb 11;15:100321. doi: 10.1016/j.lanepe.2022.100321. eCollection 2022 Apr. Lancet Reg Health Eur. 2022. PMID: 35558994 Free PMC article.
The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls.
Lawn W, Fernandez-Vinson N, Mokrysz C, Hogg G, Lees R, Trinci K, Petrilli K, Borissova A, Ofori S, Waters S, Michór P, Wall MB, Freeman TP, Curran HV. Lawn W, et al. Among authors: waters s. Psychopharmacology (Berl). 2022 May;239(5):1629-1641. doi: 10.1007/s00213-022-06143-3. Epub 2022 Apr 29. Psychopharmacology (Berl). 2022. PMID: 35486121 Free PMC article.
Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect.
Wong SL, Awatade NT, Astore MA, Allan KM, Carnell MJ, Slapetova I, Chen PC, Setiadi J, Pandzic E, Fawcett LK, Widger JR, Whan RM, Griffith R, Ooi CY, Kuyucak S, Jaffe A, Waters SA. Wong SL, et al. Among authors: waters sa. Am J Respir Cell Mol Biol. 2022 Jul;67(1):99-111. doi: 10.1165/rcmb.2021-0337OC. Am J Respir Cell Mol Biol. 2022. PMID: 35471184 Free PMC article.
Individual differences in vocal size exaggeration.
Belyk M, Waters S, Kanber E, Miquel ME, McGettigan C. Belyk M, et al. Among authors: waters s. Sci Rep. 2022 Feb 16;12(1):2611. doi: 10.1038/s41598-022-05170-6. Sci Rep. 2022. PMID: 35173178 Free PMC article.
Molecular dynamics and functional characterization of I37R-CFTR lasso mutation provide insights into channel gating activity.
Wong SL, Awatade NT, Astore MA, Allan KM, Carnell MJ, Slapetova I, Chen PC, Capraro A, Fawcett LK, Whan RM, Griffith R, Ooi CY, Kuyucak S, Jaffe A, Waters SA. Wong SL, et al. Among authors: waters sa. iScience. 2021 Dec 31;25(1):103710. doi: 10.1016/j.isci.2021.103710. eCollection 2022 Jan 21. iScience. 2021. PMID: 35072004 Free PMC article.
A bacterial index to estimate lake trophic level: National scale validation.
Pearman JK, Wood SA, Vandergoes MJ, Atalah J, Waters S, Adamson J, Thomson-Laing G, Thompson L, Howarth JD, Hamilton DP, Pochon X, Biessy L, Brasell KA, Dahl J, Ellison R, Fitzsimons SJ, Gard H, Gerrard T, Gregersen R, Holloway M, Li X, Kelly DJ, Martin R, McFarlane K, McKay NP, Moody A, Moy CM, Naeher S, Newnham R, Parai R, Picard M, Puddick J, Rees ABH, Reyes L, Schallenberg M, Shepherd C, Short J, Simon KS, Steiner K, Šunde C, Terezow M, Tibby J. Pearman JK, et al. Among authors: waters s. Sci Total Environ. 2022 Mar 15;812:152385. doi: 10.1016/j.scitotenv.2021.152385. Epub 2021 Dec 21. Sci Total Environ. 2022. PMID: 34942258
Fluid mechanical modeling of the upper urinary tract.
Zheng S, Carugo D, Mosayyebi A, Turney B, Burkhard F, Lange D, Obrist D, Waters S, Clavica F. Zheng S, et al. Among authors: waters s. WIREs Mech Dis. 2021 Nov;13(6):e1523. doi: 10.1002/wsbm.1523. Epub 2021 Mar 14. WIREs Mech Dis. 2021. PMID: 34730288 Review.
Sequencing Directly from Clinical Specimens Reveals Genetic Variations in HCMV-Encoded Chemokine Receptor US28 That May Influence Antibody Levels and Interactions with Human Chemokines.
Waters S, Agostino M, Lee S, Ariyanto I, Kresoje N, Leary S, Munyard K, Gaudieri S, Gaff J, Irish A, Keil AD, Price P, Allcock RJN. Waters S, et al. Microbiol Spectr. 2021 Oct 31;9(2):e0002021. doi: 10.1128/Spectrum.00020-21. Epub 2021 Oct 27. Microbiol Spectr. 2021. PMID: 34704798 Free PMC article.
Blue Waters, Green Bottoms: Benthic Filamentous Algal Blooms Are an Emerging Threat to Clear Lakes Worldwide.
Vadeboncoeur Y, Moore MV, Stewart SD, Chandra S, Atkins KS, Baron JS, Bouma-Gregson K, Brothers S, Francoeur SN, Genzoli L, Higgins SN, Hilt S, Katona LR, Kelly D, Oleksy IA, Ozersky T, Power ME, Roberts D, Smits AP, Timoshkin O, Tromboni F, Zanden MJV, Volkova EA, Waters S, Wood SA, Yamamuro M. Vadeboncoeur Y, et al. Among authors: waters s. Bioscience. 2021 Jul 7;71(10):1011-1027. doi: 10.1093/biosci/biab049. eCollection 2021 Oct. Bioscience. 2021. PMID: 34616235 Free PMC article.
Transcriptomic response to elevated water temperatures in adult migrating Yukon River Chinook salmon (Oncorhynchus tshawytscha).
Bowen L, von Biela VR, McCormick SD, Regish AM, Waters SC, Durbin-Johnson B, Britton M, Settles ML, Donnelly DS, Laske SM, Carey MP, Brown RJ, Zimmerman CE. Bowen L, et al. Among authors: waters sc. Conserv Physiol. 2020 Sep 11;8(1):coaa084. doi: 10.1093/conphys/coaa084. eCollection 2020. Conserv Physiol. 2020. PMID: 34512988 Free PMC article.
Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS.
Waters S, Swanson MEV, Dieriks BV, Zhang YB, Grimsey NL, Murray HC, Turner C, Waldvogel HJ, Faull RLM, An J, Bowser R, Curtis MA, Dragunow M, Scotter E. Waters S, et al. Acta Neuropathol Commun. 2021 Aug 26;9(1):144. doi: 10.1186/s40478-021-01244-0. Acta Neuropathol Commun. 2021. PMID: 34446086 Free PMC article.
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer.
Saura C, Matito J, Oliveira M, Wildiers H, Brufksy AM, Waters SH, Hurvitz SA, Moy B, Kim SB, Gradishar WJ, Queiroz GS, Cronemberger E, Wallweber GJ, Bebchuk J, Keyvanjah K, Lalani AS, Bryce R, Vivancos A, Eli LD, Delaloge S. Saura C, et al. Among authors: waters sh. Clin Cancer Res. 2021 Nov 1;27(21):5818-5827. doi: 10.1158/1078-0432.CCR-21-1584. Epub 2021 Aug 11. Clin Cancer Res. 2021. PMID: 34380637 Clinical Trial.
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
Coombes RC, Tovey H, Kilburn L, Mansi J, Palmieri C, Bartlett J, Hicks J, Makris A, Evans A, Loibl S, Denkert C, Murray E, Grieve R, Coleman R, Borley A, Schmidt M, Rautenberg B, Kunze CA, Rhein U, Mehta K, Mousa K, Dibble T, Lu XL, von Minckwitz G, Bliss JM; Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators. Coombes RC, et al. JAMA Oncol. 2021 Sep 1;7(9):1291-1301. doi: 10.1001/jamaoncol.2021.2193. JAMA Oncol. 2021. PMID: 34264305 Free PMC article. Clinical Trial.
Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.
Flores-Oria CA, Saturno E, Ramanathan S, Martinez Castillo DJ, Kumar R, Ferrer N, Mossaad A, Tellez ME, Jon C, Waters SC, Mosquera RA. Flores-Oria CA, et al. Among authors: waters sc. SAGE Open Med Case Rep. 2021 Jun 30;9:2050313X211029699. doi: 10.1177/2050313X211029699. eCollection 2021. SAGE Open Med Case Rep. 2021. PMID: 34262773 Free PMC article.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
646 results